197 related articles for article (PubMed ID: 20495473)
1. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?
Sandler AD; Glesne CE; Bodfish JW
J Dev Behav Pediatr; 2010 Jun; 31(5):369-75. PubMed ID: 20495473
[TBL] [Abstract][Full Text] [Related]
2. Open-label use of placebos in the treatment of ADHD: a pilot study.
Sandler AD; Bodfish JW
Child Care Health Dev; 2008 Jan; 34(1):104-10. PubMed ID: 18171451
[TBL] [Abstract][Full Text] [Related]
3. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
4. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD.
Sandler A; Glesne C; Geller G
Child Care Health Dev; 2008 Jan; 34(1):111-20. PubMed ID: 18171452
[TBL] [Abstract][Full Text] [Related]
5. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
Scheffer RE; Kowatch RA; Carmody T; Rush AJ
Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
[TBL] [Abstract][Full Text] [Related]
8. SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.
Brams M; Childress AC; Greenbaum M; Yu M; Yan B; Jaffee M; Robertson B
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):19-28. PubMed ID: 28816509
[TBL] [Abstract][Full Text] [Related]
9. Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.
Santisteban JA; Stein MA; Bergmame L; Gruber R
CNS Drugs; 2014 Sep; 28(9):825-33. PubMed ID: 25056567
[TBL] [Abstract][Full Text] [Related]
10. Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder.
Childress AC; Kando JC; King TR; Pardo A; Herman BK
J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):2-8. PubMed ID: 30575407
[TBL] [Abstract][Full Text] [Related]
11. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
Mattingly G; Arnold V; Yan B; Yu M; Robertson B
J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):549-557. PubMed ID: 33185468
[No Abstract] [Full Text] [Related]
12. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study.
Spencer TJ; Adler LA; Weisler RH; Youcha SH
J Clin Psychiatry; 2008 Sep; 69(9):1437-48. PubMed ID: 19012813
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
Childress AC; Brams M; Cutler AJ; Kollins SH; Northcutt J; Padilla A; Turnbow JM
J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):402-14. PubMed ID: 25692608
[TBL] [Abstract][Full Text] [Related]
15. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
Swanson JM; Greenhill LL; Lopez FA; Sedillo A; Earl CQ; Jiang JG; Biederman J
J Clin Psychiatry; 2006 Jan; 67(1):137-47. PubMed ID: 16426100
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
Wigal T; Brams M; Frick G; Yan B; Madhoo M
Postgrad Med; 2018 Jun; 130(5):481-493. PubMed ID: 29809075
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.
Stein MA; Waldman I; Newcorn J; Bishop J; Kittles R; Cook EH
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):238-44. PubMed ID: 24813374
[TBL] [Abstract][Full Text] [Related]
18. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.
Pelham WE; Gnagy EM; Chronis AM; Burrows-MacLean L; Fabiano GA; Onyango AN; Meichenbaum DL; Williams A; Aronoff HR; Steiner RL
Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
20. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]